The GLP-1 receptor agonist/metformin combination did not support weight loss in this population but did increase pregnancy rates per in vitro embryo transfer.
Gregory M. Weiss, MD
In a new study, the GLP-1 receptor agonist semaglutide was associated with greater weight loss than placebo -- and liraglutide.
Fasting sounds like a bad idea for anyone with type 2 diabetes and especially bad for someone taking antihyperglycemic drugs. But, is it really?
The ability to monitor glucose levels quite literally with the blink of an eye has gotten one step closer to clinical application. Get a quick review.
The influenza virus can be debilitating for your diabetes patients for many reasons. Here are some tips to help you help them stay safe this year.
The Jackson Heart Study found that smoking intensity and dose were associated with impaired pancreatic beta cell function in African Americans.